Login / Signup

Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial.

Laibah Arshad KhanMuhammad Shahzeb KhanAndrew P AmbrosyStephen J Greene
Published in: Heart failure reviews (2024)
Keyphrases
  • type diabetes
  • clinical trial
  • phase iii
  • randomized controlled trial
  • acute heart failure
  • atrial fibrillation
  • replacement therapy